glp-1 not injected Half of users ditch their injections — and some are turning to other weight-loss methods instead GLP-1 Injections for Medical Weight
Description
Clinicians should monitor for hypoglycemia in patients taking GLP-1 receptor agonists with insulin or sulfonylureas
PLoS ONE (2014) 9:e101005
& Yue, Y
These issues can lead to more burping on their own
In a phase I clinical trial, patients who were overweight or obese were able to reduce their body weight by 4.8% (3 mg dosage), 6.4% (4.5 mg), and 6.0% (6 mg) after receiving a once-weekly dose of mazdutide [51]
